HIGHLIGHTS
- who: Epigenetic drug screening defines et al. from the Technical University Ulm, Ulm, Germany have published the paper: Authorship note: FO and KL are co- first authors. Conflict of interest: The authors have declared that no conflict of interest exists, in the Journal: (JOURNAL) of May/12,/2021
- what: Since MYC protein expression involves control mechanisms integrated by the 3u2032-UTR of the MYC mRNA and such control is engaged by cellular stress pathways , the authors aimed to establish a model where MYC expression is driven from the endogenous promoter. In this model, the authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.